HomeCompareCHEK vs PEP

CHEK vs PEP: Dividend Comparison 2026

CHEK yields 119.05% · PEP yields 3.63%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CHEK wins by $8.10M in total portfolio value
10 years
CHEK
CHEK
● Live price
119.05%
Share price
$1.68
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.24M
Annual income
$3,108,090.72
Full CHEK calculator →
PEP
PepsiCo Inc.
● Live price
3.63%
Share price
$156.82
Annual div
$5.69
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$141.9K
Annual income
$61,875.67
Full PEP calculator →

Portfolio growth — CHEK vs PEP

📍 CHEK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCHEKPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CHEK + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CHEK pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CHEK
Annual income on $10K today (after 15% tax)
$10,119.05/yr
After 10yr DRIP, annual income (after tax)
$2,641,877.11/yr
PEP
Annual income on $10K today (after 15% tax)
$308.41/yr
After 10yr DRIP, annual income (after tax)
$52,594.32/yr
At 15% tax rate, CHEK beats the other by $2,589,282.79/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CHEK + PEP for your $10,000?

CHEK: 50%PEP: 50%
100% PEP50/50100% CHEK
Portfolio after 10yr
$4.19M
Annual income
$1,584,983.20/yr
Blended yield
37.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

CHEK
Analyst Ratings
4
Buy
2
Hold
Consensus: Buy
Altman Z
-715.9
Piotroski
2/9
PEP
Analyst Ratings
1
Strong
15
Buy
27
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+10.0% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CHEK buys
0
PEP buys
0
No recent congressional trades found for CHEK or PEP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCHEKPEP
Forward yield119.05%3.63%
Annual dividend / share$2.00$5.69
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$8.24M$141.9K
Annual income after 10y$3,108,090.72$61,875.67
Total dividends collected$7.49M$123.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold

Year-by-year: CHEK vs PEP ($10,000, DRIP)

YearCHEK PortfolioCHEK Income/yrPEP PortfolioPEP Income/yrGap
1← crossover$22,605$11,904.76$10,849$509.42+$11.8KCHEK
2$49,337$25,149.94$11,969$750.47+$37.4KCHEK
3$104,092$51,301.04$13,500$1,124.14+$90.6KCHEK
4$212,533$101,154.53$15,680$1,721.66+$196.9KCHEK
5$420,434$193,023.94$18,929$2,715.34+$401.5KCHEK
6$806,726$356,861.32$24,023$4,450.80+$782.7KCHEK
7$1,503,143$639,946.75$32,510$7,669.92+$1.47MCHEK
8$2,722,746$1,114,383.27$47,709$14,093.60+$2.68MCHEK
9$4,799,842$1,886,503.76$77,415$28,083.48+$4.72MCHEK
10$8,243,922$3,108,090.72$141,922$61,875.67+$8.10MCHEK

CHEK vs PEP: Complete Analysis 2026

CHEKStock

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

Full CHEK Calculator →

PEPConsumer Staples

PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.

Full PEP Calculator →
📬

Get this CHEK vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CHEK vs SCHDCHEK vs JEPICHEK vs OCHEK vs KOCHEK vs MAINCHEK vs MOCHEK vs PMCHEK vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.